title: Cognitive behavior therapy for schizophrenia.
abstract: OBJECTIVE
  A growing body of evidence supports the use of cognitive behavior therapy for the treatment of schizophrenia. A course of cognitive behavior therapy, added to the antipsychotic regimen, is now considered to be an appropriate standard of care in the United Kingdom. The objective of this article is to offer a broad perspective on the subject of cognitive behavior therapy for schizophrenia for the American reader.
  
  
  METHODS
  The authors summarize current practice and data supporting the use of cognitive behavior therapy for schizophrenia.
  
  
  RESULTS
  Five aspects of cognitive behavior therapy for schizophrenia are addressed: 1) evidence from randomized clinical trials, 2) currently accepted core techniques, 3) similarities to and differences from other psychosocial interventions for schizophrenia, 4) differences between the United States and United Kingdom in implementation, and 5) current directions of research.
  
  
  CONCLUSIONS
  The strength of the evidence supporting cognitive behavior therapy for schizophrenia suggests that this technique should have more attention and support in the United States.
authors.affiliation: Department of Psychiatry, Royal Victoria Infirmary, Newcastle-upon-Tyne, Tyne and Wear NE4 4LP, UK. douglas.turkington@ncl.ac.uk
authors.forename: Douglas
authors.initials: D
authors.lastname: Turkington
authors.forename: David
authors.initials: D
authors.lastname: Kingdon
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Weiden
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D003431:Cross-Cultural Comparison; D006801:Humans; D010349:Patient Compliance; D010818:Practice Patterns, Physicians'; D011575:Psychoanalytic Therapy; D011613:Psychotherapy; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012107:Research Design / Q000639:trends; D012559:Schizophrenia / Q000188:drug therapy / Q000534:rehabilitation / Q000628:therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome; D006113:United Kingdom; D014481:United States
chemical_list: D014150:Antipsychotic Agents